Ketamine Use Among People Who Regularly Use Ecstasy and Other Illicit Stimulants in Australia: Trends and Characteristics of Use, 2009-2019.


Journal

Journal of studies on alcohol and drugs
ISSN: 1938-4114
Titre abrégé: J Stud Alcohol Drugs
Pays: United States
ID NLM: 101295847

Informations de publication

Date de publication:
03 2021
Historique:
entrez: 7 4 2021
pubmed: 8 4 2021
medline: 16 6 2021
Statut: ppublish

Résumé

Ketamine is a dissociative anesthetic used in medical practice, used recreationally since the mid-1960s. This study describes trends in ketamine use in sentinel cross-sectional samples of Australians who regularly use illicit stimulants, along with characteristics of consumers. Data on trends in recent ketamine use (i.e., use in past 6 months) were drawn from annual interviews (approximately 800/year) with cross-sectional samples of people recruited from Australian state capitals from 2009 to 2019 as part of the Ecstasy and Related Drugs Reporting System (EDRS) study. Characteristics of those reporting recent use were examined in the 2019 EDRS data set (n = 728) using logistic regression. Recent ketamine use increased between 2009 and 2019 (10% to 41%, respectively, p < .001), primarily driven by use among participants recruited in Melbourne (21% to 84%, p < .001) and Sydney (19% to 68%, p < .001). However, frequency of use remained low. In 2019, consumer characteristics associated with use included being born outside of Australia and residing in Sydney or Melbourne (compared with Canberra). Among EDRS participants in Australia, we observed an increase in recent ketamine use between 2009 and 2019, although indicators of potential problematic use remained low. The increase in recent ketamine use was largely driven by increases in Melbourne and Sydney. Further research on drivers of use in these cities is required to effectively inform harm-reduction strategies.

Identifiants

pubmed: 33823965

Substances chimiques

Central Nervous System Stimulants 0
Illicit Drugs 0
Ketamine 690G0D6V8H
N-Methyl-3,4-methylenedioxyamphetamine KE1SEN21RM

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

188-196

Déclaration de conflit d'intérêts

Paul Dietze has received investigator-driven funding from Gilead Sciences and Indivior for work unrelated to this study. Paul Dietze and Simon Lenton have served as unpaid members of an Advisory Board for an intranasal naloxone product. Amy Peacock has received investigator-driven united educational funding from Mundipharma and Seqirus for work unrelated to this study. All other authors have no competing interests to declare.

Auteurs

Ashleigh C Stewart (AC)

Behaviours and Health Risks, Burnet Institute, Melbourne, Australia.
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Amy Peacock (A)

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
University of Tasmania, Hobart, Australia.

Filip Djordjevic (F)

Behaviours and Health Risks, Burnet Institute, Melbourne, Australia.

Reece Cossar (R)

Behaviours and Health Risks, Burnet Institute, Melbourne, Australia.
Centre for Forensic Behavioural Science, Swinburne University, Melbourne, Australia.

Caroline Salom (C)

Institute for Social Science Research, The University of Queensland, Brisbane, Australia.

Simon Lenton (S)

National Drug Research Institute, Curtin University, Perth, Western Australia.

Paul Dietze (P)

Behaviours and Health Risks, Burnet Institute, Melbourne, Australia.
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH